A detailed history of Stonebrook Private Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Stonebrook Private Inc. holds 2,176 shares of NVO stock, worth $243,581. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,176
Previous 2,138 1.78%
Holding current value
$243,581
Previous $275 Million 13.14%
% of portfolio
0.09%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$122.71 - $146.91 $4,662 - $5,582
38 Added 1.78%
2,176 $311 Million
Q1 2024

May 07, 2024

SELL
$102.11 - $135.92 $13,376 - $17,805
-131 Reduced 5.77%
2,138 $275 Million
Q4 2023

Feb 05, 2024

BUY
$87.78 - $105.45 $199,172 - $239,266
2,269 New
2,269 $235 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Stonebrook Private Inc. Portfolio

Follow Stonebrook Private Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonebrook Private Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stonebrook Private Inc. with notifications on news.